Endometriosis: From delayed diagnosis to precision medicine

In: International Journal of Science and Research Archive · 2026 · vol. 18(1) , pp. 306–314 · doi:10.30574/ijsra.2026.18.1.0042 · W7124485683
Review OA: hybrid CC0
⚙ AI-generated summary by qwen3.7-flash, 2026-11-06 ⓘ

This review analyzes the biological complexity and diagnostic challenges of endometriosis, highlighting how non-invasive biomarkers and precision medicine strategies aim to reduce the significant delay in diagnosis and improve personalized patient care.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-09-27 · read from full text ⓘ

This review article examines the biological complexity of endometriosis as a heterogeneous, estrogen-dependent inflammatory disorder characterized by significant diagnostic delays averaging six to ten years. The authors synthesize emerging evidence on non-invasive diagnostic innovations, such as circulating biomarkers, advanced imaging, and artificial intelligence, which aim to reduce reliance on surgical diagnosis. They further explore how integrative omics approaches and molecular stratification are facilitating a transition toward precision medicine to predict treatment responses and guide personalized therapeutic strategies. This paper is centrally about endometriosis — specifically focusing on the challenges of delayed diagnosis and the potential for precision medicine interventions.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Endometriosis is a chronic, estrogen-dependent inflammatory disorder affecting approximately 10% of individuals of reproductive age worldwide and remains one of the most underdiagnosed and heterogeneous conditions in women’s health. Increasing evidence demonstrates that endometriosis is not a single disease entity but a complex, multifactorial spectrum driven by hormonal imbalance, immune dysregulation, chronic inflammation, neuroangiogenesis, and genetic and epigenetic alterations. Profound disease heterogeneity across anatomical presentation, symptom severity, molecular profiles, and treatment response poses major challenges to diagnosis and management. A persistent diagnostic delay averaging 6–10 years from symptom onset continues to result in disease progression, chronic pain, infertility, psychological distress, and substantial socioeconomic burden. This review examines the biological complexity of endometriosis and critically analyzes the causes and consequences of diagnostic delay. We synthesize emerging evidence on non-invasive diagnostic innovations, including circulating and menstrual biomarkers, microRNAs, advanced imaging modalities, and artificial intelligence–based tools, which collectively challenge the historical reliance on surgical diagnosis. We further explore how integrative “omics” approaches and molecular stratification are enabling the transition toward precision medicine, with the potential to predict treatment response and guide personalized therapeutic strategies. Despite significant advances, barriers to clinical translation remain, including lack of standardized biomarkers, limited validation of AI models, and inequitable access to expert imaging. Addressing these challenges through coordinated research, education, and health system reform is essential. The integration of molecular profiling, non-invasive diagnostics, and patient-centered multidisciplinary care offers a transformative opportunity to reduce diagnostic delay and shift endometriosis management from reactive symptom control toward predictive, personalized care.
Full text 2,857 characters · extracted from oa-html · click to expand
1 Department of Obstetrics and Gynaecology, Enugu State University Teaching Hospital, Parklane, Enugu, Nigeria. 2 Department of Paediatrics, Alberta Children Hospital Calgary, Canada. International Journal of Science and Research Archive, 2026, 18(01), 306-314 Article DOI: 10.30574/ijsra.2026.18.1.0042 Received on 03 December 2025; revised on 09 January 2026; accepted on 12 January 2026 Endometriosis is a chronic, estrogen-dependent inflammatory disorder affecting approximately 10% of individuals of reproductive age worldwide and remains one of the most underdiagnosed and heterogeneous conditions in women’s health. Increasing evidence demonstrates that endometriosis is not a single disease entity but a complex, multifactorial spectrum driven by hormonal imbalance, immune dysregulation, chronic inflammation, neuroangiogenesis, and genetic and epigenetic alterations. Profound disease heterogeneity across anatomical presentation, symptom severity, molecular profiles, and treatment response poses major challenges to diagnosis and management. A persistent diagnostic delay averaging 6–10 years from symptom onset continues to result in disease progression, chronic pain, infertility, psychological distress, and substantial socioeconomic burden. This review examines the biological complexity of endometriosis and critically analyzes the causes and consequences of diagnostic delay. We synthesize emerging evidence on non-invasive diagnostic innovations, including circulating and menstrual biomarkers, microRNAs, advanced imaging modalities, and artificial intelligence–based tools, which collectively challenge the historical reliance on surgical diagnosis. We further explore how integrative “omics” approaches and molecular stratification are enabling the transition toward precision medicine, with the potential to predict treatment response and guide personalized therapeutic strategies. Despite significant advances, barriers to clinical translation remain, including lack of standardized biomarkers, limited validation of AI models, and inequitable access to expert imaging. Addressing these challenges through coordinated research, education, and health system reform is essential. The integration of molecular profiling, non-invasive diagnostics, and patient-centered multidisciplinary care offers a transformative opportunity to reduce diagnostic delay and shift endometriosis management from reactive symptom control toward predictive, personalized care. Endometriosis; Diagnostic delay; Precision medicine; Disease heterogeneity Preview Article PDF Onah, Livinus Nnanyereugo, Ezenwaeze, Malachy Nwaeze and Nwankwo, Chibugo Ndidiamaka. Endometriosis: From delayed diagnosis to precision medicine. International Journal of Science and Research Archive, 2026, 18(01), 306-314. Article DOI: https://doi.org/10.30574/ijsra.2026.18.1.0042.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-html ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosisinfertility

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (1)

Cited by (1)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK